We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Feather Safety Razor

Download Mobile App





Lung Ultrasound as Good as Chest X-Ray for COVID-19 Diagnosis and Management

By HospiMedica International staff writers
Posted on 25 Jan 2022
Print article
Illustration
Illustration

A retrospective multicenter study by researchers from Italy, Portugal and Spain has found lung ultrasound (LUS) to be as good as chest X-ray (CXR) for accurate COVID-19 diagnosis.

LUS holds the promise of an accurate, radiation-free, and affordable diagnostic and monitoring tool in coronavirus disease 2019 (COVID-19) pneumonia. The researchers sought to evaluate the usefulness of LUS in the diagnosis of patients with respiratory distress and suspicion of interstitial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia, in comparison to other imaging modalities.

In the study, study, LUS was performed on Emergency Department (ED) arrival of patients presenting for possible COVID-19 evaluation, by trained emergency physicians, before undergoing conventional radiologic examination or while waiting for the report. Scans were performed using longitudinal transducer orientation of the lung regions. CXR was interpreted by radiologists staffing ED radiology. The subjects were divided into two groups based on molecular test results. The LUS findings were compared to COVID test results, non-laboratory data, and other imaging for each patient. Categorical variables were expressed as percentages and continuous variables as median ± standard error.

A total of 479 patients were enrolled, out of which 87% were diagnosed with SARS-CoV-2 by molecular testing. COVID positive and COVID negative patients differed with respect to sex, presence of fever, and white blood cells count. The most common findings on lung point of care ultrasound (POCUS) for COVID-positive patients were B-lines, irregular pleural lines, and small consolidation. Normal CXR was found in 17.89% of cases. The study found LUS to be non-inferior to CXR for diagnostic accuracy and COVID-positive patients were most likely to show B lines and sub-pleural consolidations on LUS examination.


Print article

Channels

Critical Care

view channel
Image: EsoGuard has demonstrated over 90% specificity and 90% sensitivity in identifying Barrett’s Esophagus (Photo courtesy of Lucid Diagnostics)

Biomarker Based Non-Endoscopic Technology Identifies Risk for Esophageal Cancer

Barrett's esophagus (BE) is the benign and treatable precursor condition to esophageal adenocarcinomas (EAC) which is usually diagnosed at an advanced stage and is difficult to treat. Finding BE, a sign... Read more

Surgical Techniques

view channel
Image: Novel surface treatment could prevent deadly hospital infections without antibiotics (Photo courtesy of Penn State)

Novel Surface Treatment Stops Microbes from Adhering to Medical Devices

Hospitals and medical clinics can be the source of nasty infections, resulting in death from infection-related complications and billions in direct medical costs. The biggest culprits, experts say - accounting... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.